CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study 3D Printing and Heart Failure: The Present and the Future Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review Angiotensin–neprilysin inhibition versus enalapril in heart failure 中国心力衰竭诊断和治疗指南2018

Clinical TrialFebruary 6, 2018, Volume 137, Issue 6

JOURNAL:Circulation Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group. Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF